GENENTA SCIENCE S.P.A. American Depositary Shares each representing one ordinary share, no par value per share ATM Sales AgreementGenenta Science S.p.A. • April 26th, 2024 • Biological products, (no disgnostic substances) • New York
Company FiledApril 26th, 2024 Industry JurisdictionGenenta Science S.p.A., a Republic of Italy joint stock corporation (the “Company”), confirms its agreement (this “Agreement”) with Virtu Americas LLC and Capital One Securities, Inc. (each individually an “Agent” and together, the “Agents”), as follows:
SEABRIDGE GOLD INC. Common Shares (no par value per share) Controlled Equity OfferingSM Sales AgreementSeabridge Gold Inc • January 9th, 2023 • Gold and silver ores • New York
Company FiledJanuary 9th, 2023 Industry JurisdictionSeabridge Gold Inc. (the “Company”), a company continued under Canada Business Corporations Act, confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Lead Agent”) and B. Riley Securities, Inc. (collectively with the Lead Agent, the “Agents” and individually, an “Agent”), as follows:
SEABRIDGE GOLD INC. Common Shares (no par value per share) Controlled Equity OfferingSM Sales AgreementSeabridge Gold Inc • January 22nd, 2021 • Gold and silver ores • New York
Company FiledJanuary 22nd, 2021 Industry JurisdictionSeabridge Gold Inc. (the “Company”), a company continued under Canada Business Corporations Act, confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Lead Agent”) and B. Riley Securities, Inc. (collectively with the Lead Agent, the “Agents” and individually, an “Agent”), as follows:
SEABRIDGE GOLD INC. Common Shares (no par value per share) Controlled Equity OfferingSM Sales AgreementSeabridge Gold Inc • October 11th, 2019 • Gold and silver ores • New York
Company FiledOctober 11th, 2019 Industry JurisdictionSeabridge Gold Inc. (the “Company”), a company continued under Canada Business Corporations Act, confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Lead Agent”) and B. Riley FBR, Inc. (collectively with the Lead Agent, the “Agents” and individually, an “Agent”), as follows: